IVF Success Rates in 2026: By Age, FET, PGT-A & India Cost for Australian & UK Patients

Live delivery success rates range from 40-55% per transfer cycle for women under 35 years old in the best NABH-certified IVF facilities in India. This is on par with or above the success rates in Australian and British private clinics, which offer 60-80% cheaper services. This is especially true for Australians dealing with a minimum of 3 months to up to 6 months waiting time for government hospitals.

This guide covers IVF success rates by age, FET outcomes, PGT-A screening, and a direct cost comparison. It gives you what you need before talking to a fertility specialist.

How IVF Success Rates Are Measured — and What to Ask Your Clinic

Success rate claims vary widely across clinics — often because they’re measuring different things. Before comparing any figures, you need to know which metric is being used.

Live Birth Rate vs Clinical Pregnancy Rate: What’s the Difference?

Live birth rate (LBR) refers to the proportion of transfers that lead to a live delivery. This is the most important statistic from a patient perspective. Clinical pregnancy rate (CPR) is the number of transfers resulting in a heartbeat at 6 to 8 weeks. This figure is higher since it includes miscarriages. Some centers cite CPR as a more attractive figure. You should always ask about LBR per embryo transfer in your age bracket.

Two other reporting variations matter. Success rate per cycle started is lower than per transfer. It counts cancelled cycles — where stimulation produced no viable embryos. Success rate per transfer is the figure most comparable across clinics. At NABH-accredited hospitals — Apollo Chennai, Fortis Noida, Medanta Gurgaon, and MAX — international patient reporting follows ICMR ART guidelines. These standardise live birth rate per transfer.

IVF Success Rates by Age: The Full Breakdown

 Age proves to be the key determinant of the success rate of IVF. Age affects the number and quality of eggs much more than anything else within the IVF process. The following table presents the rate of successful live births for various age groups.

Age Group	Live Birth Rate (India, top clinics)	Live Birth Rate (Australia avg.)	Live Birth Rate (UK — HFEA 2023)	India Advantage
Under 35	40–55%	30–40%	32–38%	+8–17 pp
35–37	30–42%	22–30%	25–32%	+5–12 pp
38–40	20–32%	14–22%	15–22%	+5–10 pp
Over 40 (own eggs)	10–18%	6–12%	5–8%	+4–10 pp
Donor egg (any age)	55–70%	45–55%	40–55%	Comparable

Data Sources: India – ICMR ART Registry database; India hospitals – Apollo Chennai, Fortis Noida, Medanta Gurgaon, MAX. Australia – Monash IVF 2025 statistics. United Kingdom – HFEA (Human Fertilisation and Embryology Authority) 2023 report. All data is reported in terms of live births per embryo transfer.

India Advantage Note: According to ICMR data, India's best centers conduct more than 50,000 IVF cycles per year. The number of cycles conducted improves the skills of the embryologists and precision in the laboratory. The quality of the embryologists and precision in the laboratory protocols improve due to higher volumes.

What Is the Success Rate of IVF on the First Try?

On a first IVF cycle, live birth rates for women under 35 at well-equipped Indian centres typically fall between 40–50%. CDC ART Data (2020) shows 55.1% live birth rates per egg retrieval for women under 35 on their first attempt. This is the most comprehensively reported ART dataset globally. India’s top clinics are in this range.

The critical nuance: ‘first try’ means different things. You may bank embryos on the first retrieval, but you need two or three frozen transfers. Most specialists still count that as ‘one retrieval cycle’ — not multiple failed attempts. Planning for 2–3 frozen transfers from a single egg retrieval is statistically common and does not mean IVF failed.

IVF Success Rate for Women Under 35 (and Under 30)

Women under 30 have the highest live birth rates of any age group. Typical rates are 45–55% per transfer at well-resourced Indian fertility centres. This comes from higher antral follicle counts, better egg quality, and fewer chromosomal abnormalities per egg. More eggs are also retrieved per stimulation cycle.

For women aged 30–34, outcomes are similar but begin to taper slightly — live birth rates of 38–48% are typical. The drop from under-30 to early 30s is modest. The more significant decline begins around 35, which is why the 35-year threshold appears in most clinical guidelines.

At What Age Is IVF Most Successful?

IVF is most successful under the age of 35, and specifically most successful for women in their mid-to-late 20s. This reflects biological reality. A woman’s ovarian reserve and egg quality are at their peak before 30. Both begin declining measurably after 35. The decline is gradual between 30–35 and accelerates after 38. The decline is gradual between 30–35 and accelerates after 38.

For patients over 40 using their own eggs, live birth rates at Indian fertility centres are 10–18% per transfer. Donor egg IVF raises this to 55–70% regardless of the recipient’s age. The outcome depends on the donor’s egg quality — not the recipient’s.

At What Age Are 90% of Your Eggs Gone?

Research suggests that by age 30, a woman has approximately 12% of her original egg supply remaining. By 40, that figure falls to around 3%. The widely cited ‘90% gone by 30’ figure is broadly consistent with data in Human Reproduction (2010, Wallace & Kelsey). Individual variation is significant. What matters clinically is not total egg count. AMH (anti-Müllerian hormone) level and antral follicle count are what directly predict your response to ovarian stimulation. Your fertility specialist will measure these in the first consultation.

What Is PGT-A and How Does It Improve IVF Success?

PGT-A (Preimplantation Genetic Testing for Aneuploidy) is a procedure that screens embryos for chromosomal abnormalities before transfer. Aneuploid embryos have the wrong number of chromosomes. They are the primary cause of failed implantation and early miscarriage. PGT-A identifies and excludes them, so only chromosomally normal (euploid) embryos are transferred.

What Exactly Does PGT-A Test For?

PGT-A screens all 24 chromosome pairs (22 autosomal + X and Y) for extra or missing copies. Common aneuploidies include trisomy 21 (Down syndrome), trisomy 18, trisomy 13, and monosomy X (Turner syndrome). A few cells are biopsied from the embryo at the blastocyst stage (day 5 or 6). These are then analysed via next-generation sequencing (NGS). The embryo is frozen during testing; results take 1–2 weeks.

PGT-A also detects segmental aneuploidies — partial chromosome duplications or deletions. It also detects mosaicism: embryos with a mix of normal and abnormal cells. Mosaic embryos require specialist counselling before transfer; many are still viable, but with lower success rates than fully euploid embryos.

Does PGT-A Detect Down Syndrome?

Yes. PGT-A detects trisomy 21 (Down syndrome) alongside all other aneuploidies. It screens the entire chromosome complement, not just specific conditions. This is what differentiates PGT-A from older, targeted genetic tests. PGT-A does not detect single-gene disorders such as cystic fibrosis or BRCA mutations. Those require PGT-M (monogenic) testing — a separate and more complex procedure.

What Is the Difference Between PGT and PGT-A?

PGT (Preimplantation Genetic Testing) is the umbrella term for all forms of embryo genetic screening. PGT-A is the specific subtype that screens for aneuploidy (abnormal chromosome number). Other subtypes include PGT-M (screens for inherited single-gene conditions) and PGT-SR (for patients who carry chromosomal translocations). When fertility specialists say ‘PGT,’ they usually mean PGT-A unless specified otherwise. At Apollo Hospitals Chennai and Medanta Gurgaon, PGT-A is a standard IVF add-on. It follows ICMR ART guidelines.

PGT-A impact on success rates: For women under 35, PGT-A typically increases per-transfer live birth rates to 55–70% by ensuring only euploid embryos are transferred. For women over 38, aneuploid embryos are far more common. The benefit of PGT-A is even greater at this age. It reduces the number of failed transfers and miscarriages before a successful pregnancy.

Frozen Embryo Transfer Success Rates: What the Data Shows

The procedure used in most large volume clinics around the world is frozen embryo transfer (FET). Another name for this process is cryopreserved embryo transfer. Research findings indicate that FET results are either equivalent to or slightly superior to fresh embryo transfer.

Is IVF More Successful With Frozen Embryos?

For most patients, yes — particularly those who respond well to ovarian stimulation. The key reason is uterine receptivity. During a fresh IVF cycle, the uterus is in a hormonally elevated state from stimulation medications. This can reduce implantation rates. A frozen cycle allows the uterus to be prepared separately, in a more natural hormonal environment. This improves the chance of the embryo attaching.

Factor	Fresh Transfer	Frozen Transfer (FET)	Why It Matters
Timing	3–5 days post-retrieval	Separate cycle — weeks/months later	FET allows body to fully recover from stimulation
Uterine environment	Impacted by stimulation hormones	Prepared separately; optimal receptivity	Better lining = better implantation odds
Live birth rate (under 35)	35–45%	40–50%	FET generally outperforms in high-responders
OHSS risk	Present (stimulation + transfer same cycle)	Minimal (stimulation already resolved)	FET is safer for patients who over-respond
PGT-A compatibility	Limited — timing too tight	Standard — embryos frozen during testing	FET required for PGT-A screened transfers

Sources: Results from Max Healthcare FET; Data from ART Registry by ICMR; Meta-analysis by Human Reproduction Update comparing FET vs. fresh transfer results in which figures represent live birth rates per transfer at recognized fertility centers in India.

How Can I Make My Frozen Embryo Transfer Successful?

Adherence to medication is the key point here. The intake of progesterone and estrogen helps to prepare the uterus for implantation; any deviation will affect the result. Apart from the medications, the following factors have evidence-based support:

•           Blastocyst (day-5) embryos have higher implantation rates than day-3 embryos — ask your clinic what stage they plan to freeze at

•           PGT-A screening before FET reduces the likelihood of transferring an aneuploid embryo — the most common reason for transfer failure

•           Endometrial receptivity assessment (ERA test) — a biopsy that identifies the optimal day for transfer — is offered at Apollo Chennai and Fortis Noida for patients with repeated FET failures

•           Avoid strenuous exercise and high-heat environments for 7 days post-transfer

•           A diet adequate in protein and folic acid is standard recommendation; there is no specific ‘implantation diet’ with strong clinical evidence

When Do Most Embryo Transfers Fail?

Most failed transfers occur in the first 7–10 days after the procedure — during the implantation window. The embryo either fails to attach to the uterine lining or attaches briefly and then stops developing. The most common cause is chromosomal abnormalities in the embryo. These account for 60–70% of early failures per reproductive biology literature. Inadequate uterine lining preparation and suboptimal endometrial receptivity account for most of the rest.

If you have two or more failed transfers with good-quality embryos, your specialist will typically recommend investigation. This includes:

•           Hysteroscopy — to check for uterine abnormalities

•           ERA testing

•           Sperm DNA fragmentation analysis

•           A review of your stimulation protocol. This is standard practice at Medanta Gurgaon and MAX Hospitals for recurrent implantation failure patients.

What Disqualifies Someone from IVF?

Absolute medical contraindications to IVF are rare. Most patients who want IVF can access it, though the recommended protocol may vary. The conditions below either prevent IVF or require it to be modified:

•           Severe uterine abnormalities that cannot be corrected — such as significant Asherman’s syndrome (severe uterine scarring) or a uterus absent from birth. In these cases, gestational surrogacy may be the alternative.

•           Active malignancy requiring immediate treatment — cancer treatment often needs to start before IVF is feasible, though fertility preservation (egg or embryo freezing) before chemotherapy may be possible.

•           Uncontrolled systemic illness — poorly managed diabetes, uncontrolled thyroid disease, or severe cardiac conditions needs to be stabilised first.

•           Very low or absent ovarian reserve (AMH < 0.1 ng/mL) with no eggs retrieved after stimulation — donor egg IVF remains an option in these cases.

Ageing and poor ovarian reserves do not necessarily rule out treatment. They play an important role in determining the proper course of treatment, as well as the possibility of success using their own eggs; however, this option is still available to them. The fertility evaluation will determine the course of action for you.

IVF Cost in India vs Australia vs UK (2026)

 There is a significant disparity between the prices charged in India and those charged in the West. This price disparity is not due to any variation in the standard of care provided. The cost advantage that India enjoys stems from low running costs, large patient numbers, and competition in the private fertility market.

Country	Cost (1 IVF Cycle, incl. FET)	Savings vs India	Notes
India	₹1,50,000–₹3,00,000 ($1,591–$3,240)	—	NABH/JCI-accredited; most medications included
Australia	AUD 10,000–17,000 ($6,500–$12,146)	60–70% less in India	Out-of-pocket after Medicare; 3–6 month public wait-lists
UK	£5,000–£8,500 ($6,000–$11,472)	65–80% less in India	NHS covers very limited cases; private costs are above

References: Apollo Hospitals Chennai, Fortis Noida, Medanta Gurgaon, MAX Hospitals India. Australia: Monash IVF 2025 prices. United Kingdom: Bourn Hall Clinic and HFEA Private Clinic Cost Survey 2024. Figures are approximate prices for private healthcare and prices may vary depending on individual protocols such as  number of embryos, and additional services such as PGT-A, ICSI, and ERA.

 In this context, the significance of the comparison for Australian patients is even more pronounced. After taking into consideration the amount paid to Medicare, an individual IVF cycle would still cost $5,000-$10,000 on average in Australia. In addition, there are long wait-lists ranging from 3 to 6 months of public assisted reproductive health programs offered by the government in different states.

For UK patients, NHS IVF eligibility is narrow and varies by Clinical Commissioning Group. Most NHS-ineligible patients pay £5,000–£10,000 per private cycle. PGT-A in the UK adds £1,500–£3,000 to the cycle cost. In India, PGT-A is included or available as a modest add-on — typically ₹40,000–₹80,000 per embryo tested (approximately £380–£760).

How Divinheal Supports Australian &** UK Patients Travelling to India for IVF**

Divinheal matches patients to NABH-accredited hospitals based on diagnosis, age, embryo banking plan, and required techniques — not just geography. For Australian and UK patients, two patient stories illustrate what the journey typically looks like.

Australian Patient: Sarah, 34, Melbourne

Sarah had been on Victoria’s public fertility programme for 9 months. Her GP confirmed she was eligible for IVF but unlikely to be seen within 6 months. She contacted Divinheal. Her coordinator matched her to Apollo Hospitals Chennai — chosen for its blastocyst culture rates and PGT-A capability. Sarah completed her egg retrieval, PGT-A screening, and first frozen transfer in a 26-day trip. Her total India cost — including flights from Melbourne and a serviced apartment — was AUD 7,200. Her private Australian quote had been AUD 12,800 for a single cycle without PGT-A.

Stories are illustrative composites based on typical patient journeys. Names changed for privacy.

UK Patient: James &** Priya, 37 ****&**** 35, London**

James and Priya had two failed NHS-funded IVF cycles. Their NHS trust declined a third funded attempt. A private London clinic quoted £7,500 for a cycle with PGT-A. Divinheal matched them to Medanta Gurgaon. Their fertility specialist there held a DNB in Reproductive Medicine and had trained at a UK centre. Their three-cycle PGT-A programme at Medanta costs £4,200 all-in — less than a single UK cycle. Priya confirmed a viable pregnancy after the second frozen transfer.

Stories are illustrative composites based on typical patient journeys. Names changed for privacy.

What Divinheal Coordinates

Divinheal handles the full medical journey to India. This includes:

•           Clinic matching based on your age, diagnosis, required techniques (PGT-A, ICSI, donor egg, ERA), and budget

•           Hospital appointment booking at NABH-accredited partner hospitals

•           Medical visa invitation letter for Australian and UK nationals

•           Accommodation near the treatment clinic, typically 1–2 km away

•           Airport transfers on arrival and departure

•           A WhatsApp-accessible patient coordinator throughout your stay

•           Post-return telemedicine coordination with your treating specialist

Divinheal does not charge a placement fee. Partner hospital rates are direct patient pricing — not marked up. You can request a second opinion from a different partner hospital before committing.

Final Thoughts

The IVF success rates in question are realistic, quantifiable, and increasing. The best Indian infertility clinics provide live birth rates of 40% to 55% for each embryo transfer to women younger than 35 years old. This is comparable to what one would get from the best clinics in the West but at a much more affordable rate.

Contact Divinheal for a free case evaluation. This includes a cost estimate, clinic match, and consultation with a named fertility specialist. Bring your most recent AMH result, antral follicle count, and semen analysis if available.

Disclaimer: All costs are only estimated for 2025-2026 private medical costs. Medical treatment must be discussed with a certified physician. The success rates are general figures provided by the NABH certified partner hospitals and published data registries; individual results may vary. Case studies are fictionalized narratives; names have been altered for confidentiality. All sources cited must be confirmed by the Divinheal medical team prior to posting.